A Beloved Classic Just Got Sweeter Than Ever; Candy Crush Solitaire™ Launches Worldwide
6.2.2025 15:00:00 EET | Business Wire | Press release
King, the interactive entertainment company behind the world-famous Candy Crush® franchise, today launches Candy Crush Solitaire™on mobile devices worldwide. Candy Crush Solitaire brings a fresh take to the classic card game, combining the timeless fun of solitaire with the vibrant and colorful world of Candy Crush.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250206977362/en/
Candy Crush Solitaire gameplay (Graphic: King)
Candy Crush Solitaire offers players a fun, mentally stimulating challenge, combining the familiar gameplay of TriPeaks solitaire with challenging levels, innovative gameplay, and tasty rewards, as they are immersed into the sensory and whimsical Candy Crush universe.
Beloved characters join players on a sweet journey around the world, collecting Candified postcards and delicious rewards as they progress through the game, solving puzzles and stacking cards. This new mobile game offering will launch with a set of features, including the “Hold Slot,” enabling players to set cards aside for later use, or they can unleash the fan-favorite Candy Color Bomb booster - reimagined in card form - to conquer tricky levels.
“We’re excited to take a timeless card game like solitaire and reimagine it through the lens of the iconic Candy Crush brand,” said Tjodolf Sommestad, President, King. “The launch of Candy Crush Solitaire marks an important step in King’s strategy to expand our portfolio by combining classic gameplay with our expertise in creating immersive, player-focused mobile experiences. This new addition not only strengthens the Candy Crush franchise’s global reach but also delivers fresh, innovative ways for players to connect and engage with the games they love, all with that signature Candy Crush energy.”
Candy Crush Solitaire builds on the success of Candy Crush Saga, the highest-grossing mobile game of all time in the Western world since its launch [source: Data.ai]. The game has maintained its relevance and reaffirmed its position as one of the global leaders in mobile gaming.
With Candy Crush first captivating players worldwide through Candy Crush Saga, the match-3 mobile gaming phenomenon, the franchise continues to evolve, boasting over 18,000 levels and now expanding into new genres to bring its iconic fun to even more players around the globe.
Since 2023, King has been part of the Microsoft family, and when asked about the most recent solitaire game, Paul Jensen, GM of Casual Games, Microsoft said, “As the most popular card game of all time, Microsoft solitaire is hugely special to us at Microsoft. We’re thrilled to see King create an exciting new twist to solitaire as the newest addition to King’s widely loved Candy Crush franchise. The launch marks an exciting milestone as our businesses look to work together to bring more choice and innovation to the mobile gaming market in the future.”
Candy Crush Solitaire is free to download and available now on the Amazon App Store, Apple App Store, Google Play, Samsung Galaxy Store and more.
About King
With a mission of Making the World Playful, King is a leading interactive entertainment company with more than 20 years of history of delivering some of the world’s most iconic games in the mobile gaming industry, including the world-famous Candy Crush franchise, as well as other mobile game hits such as Farm Heroes Saga. King games are played by more than 200 million monthly active users. King, part of Microsoft (NASDAQ: MSFT), has Kingsters in Stockholm, Malmö, London, Barcelona, Berlin, Dublin, San Francisco, New York, Los Angeles and Malta. More information can be found at King.com or by following us on LinkedIn, @lifeatking on Instagram, or @king_games on X.
About Candy Crush Solitaire
Candy Crush Solitaire™ brings a fresh twist to the classic card game, combining the timeless fun of solitaire with the vibrant and colorful world of Candy Crush®. Players can unwind and challenge themselves as they solve puzzles, stack cards, and enjoy innovative gameplay that reimagines solitaire in a delightful new way.
Candy Crush Solitaire is free to download and available on the Apple App Store, Google Play, and Amazon App Store. Whether you’re a fan of card games or looking for a relaxing escape, Candy Crush Solitaire offers a fun and engaging experience for players of all ages.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250206977362/en/
Contacts
Global Media Contact: kingcomms@king.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom